Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Cipla
Fish and Richardson
Moodys
Express Scripts
Deloitte

Generated: July 17, 2019

DrugPatentWatch Database Preview

Patent: 7,862,995

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,862,995
Title:Methods and materials for predicting responsiveness to treatment with dual tyrosine kinase inhibitor
Abstract: The present invention relates to a panel of targeted therapy markers that can be used in assessing a particular subject\'s sensitivity to various therapeutic agents and cancer treatments as a means of prognosticating whether a treatment or use of a particular therapeutic agent will result in a clinically positive outcome. Cellular receptors, ligands to those receptors and molecules involved in the programmed cell death pathway are examples of targeted therapy markers that might be used in the present invention.
Inventor(s): Bacus; Sarah S. (Hinsdale, IL), Hill; Jason (Chicago, IL)
Assignee: Targeted Molecular Diagnostics (Westmont, IL)
Application Number:11/223,700
Patent Claims:see list of patent claims

Details for Patent 7,862,995

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25 ➤ Sign Up Targeted Molecular Diagnostics (Westmont, IL) ➤ Sign Up RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Teva
QuintilesIMS
Johnson and Johnson
US Army
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.